Type of consortium agreement describing the different types of access rights.  „IMI 2 JU is a public-private partnership that was established as a `Joint Undertaking` between the European Union and the European Pharmaceutical Industry Association and Associations (EFPIA).“ The two members of the Management Board, the main decision-making body of IMI 2 JU, are represented in the same way. See europa.eu/european-union/about-eu/agencies/imi2_en. Do you need more information on preparing and signing grant agreements? Watch this Horizon 2020 webinar for coordinators of successful proposals. All project partners must sign a consortium agreement defining the rights and obligations of the participants and addressing issues such as governance, accountability and intellectual property rights. The agreement should be adapted to the needs of each project. A model developed by EFPIA shows what a consortium agreement could look like. Consortia can also use alternative models if they wish. The IMI2 JU Model Grant Agreement (MGA) is updated from time to time in accordance with the 2020 (H2020) MGA horizon. The latest version of the IMI2 JU MGA is always available via this link.
Below are links to some versions and IMI2 calls. Please provide your last name, first name and address. In order to facilitate the identification of the requested document, we recommend that you formulate your request as clearly and accurately as possible. Requests can be sent by e-mail, fax or post. From 2015, the latest version of the annual scientific priorities will be available in the latest update of the annual work plan. In some cases (for example.B. however, if beneficial to beneficiaries), retroactive amendments may be made to projects whose grant agreements are based on earlier versions of the model grant agreement. This document explains this in more detail and summarizes what is new in versions 3 and 4 compared to previous versions and what changes are retroactive. Note that from IMI2 – Call 10, proposals must be submitted on the electronic submission system of the promotion and tender portal. Please note that a request for access to documents may fall within the exceptions provided for in Articles 4 and 9 of Regulation (EC) No 1049/2001. If you wish to access information on IMI`s work that is not available on the website and is not part of an IMI document, please send your question to: infodesk at imi.europa.eu Amending budget No On 28 February 2020, the IMI Management Board approved 2020 in order to include carry-over appropriations from the previous year and to take into account a reduction in commitment appropriations and commitment appropriations.
payment appropriations. The 2020 establishment plan remains unchanged. If you wish to obtain a document, you can send a request to IMI. Requests shall be dealt with in accordance with the provisions of Regulation (EC) No 1049/2001 of the European Parliament and of the Council regarding public access to European Parliament, Council and Commission documents and Decision IMI-GB-036-24092008 of the Management Board of IMI implementing Regulation (EC) No 1049/2001. Research and innovation actions – Proposal of the first stage under a two-stage procedure Coordination and support actions – Step 1 – Brief submission of proposals This page contains all documents relating to calls for proposals and projects launched under the IMI2 programme. It contains tender texts, documents for applicants, grant agreements and reports. 2018 Annual Work Plan (as amended by the IMI Board of Directors on 5 December 2018) Please refer to the IMI2 JU Annotated Model Grant Agreement, which outlines the specific features of the IMI2 public-private partnership and helps applicants and project participants understand and interpret the provisions of the IMI2 JU Model Grant Agreement. .